KPIs & Operating Metrics(New)
Breakdown Of AssetsCommercial Operations Revenue By CategoryConsumer Healthcare Revenue BreakdownConsumer Healthcare Revenue Breakdown AnnualContractual ObligationsEmployee StatisticsEmployee Statistics %Established Pharmaceuticals Revenue BreakdownEstablished Vaccines Revenue BreakdownGeneral Medicines By CategoryGeneral Medicines Revenue By RegionGeneral Medicines Revenue By Region AnnualHiv & Immuno Inflammation Revenue BreakdownHiv & Immuno Inflammation Revenue Breakdown AnnualHiv Revenue BreakdownHiv Revenue Breakdown AnnualMeningitis, Influenza & Shingles Revenue BreakdownMeningitis Revenue BreakdownMeningitis Revenue Breakdown AnnualNon Current Assets By Location Of SubsidiaryNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Oncology Revenue BreakdownOncology Revenue Breakdown AnnualOperating Assets By SegmentOperating Margin By Segment %Operating Profit By SegmentOpex As A % Of RevenueOPEX SegregationOther General Medicines Revenue BreakdownOther General Medicines Revenue Breakdown AnnualPharmaceuticals Revenue BreakdownPharmaceuticals Revenue Breakdown AnnualProfit By Segment AnnualProfit Margin By Segment Annual %Purchase Commitments AnnualRespiratory/Immunology And Other Revenue BreakdownRespiratory/Immunology And Other Revenue Breakdown AnnualRespiratory Revenue BreakdownRespiratory Revenue Breakdown General MedicinesRespiratory Revenue Breakdown General Medicines AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By RegionRevenue By Region %Revenue By Region % Annual %Revenue By Region AnnualRevenue By SegmentRevenue By Segment %Revenue By Segment % Annual %Revenue By Segment AnnualSpeciality Medicines Revenue By RegionSpeciality Medicines Revenue By Region AnnualVaccines Revenue BreakdownVaccines Revenue Breakdown Annual
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)
Gsk (GSK) Commercial Operations Revenue By Category (2016 - 2025)
Generated on {Timestamp}
© BusinessQuant.com
Generated on {Timestamp}
Powered by 
Peer Comparison
Historic Data
Download Data 🔒| Date | Value |
|---|---|